Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Cao, Chuanhaia; b | Cirrito, John R.c | Lin, Xiaoyanga; b | Wang, Lillyb; d | Verges, Deborah K.c | Dickson, Alexanderb; d | Mamcarz, Malgorzatab; d | Zhang, Chia; b | Mori, Takashie | Arendash, Gary W.b; d; * | Holtzman, David M.c; f; g | Potter, Huntingtona; b; h
Affiliations: [a] The Byrd Alzheimer's Center & Research Institute, Tampa, FL, USA | [b] Florida Alzheimer's Disease Research Center, University of South Florida, Tampa, FL, USA | [c] Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA | [d] Department of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, FL, USA | [e] Departments of Medical Science and Pathology, Saitama Medical Center and Saitama Medical University, Kawagoe, Saitama, Japan | [f] Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA | [g] Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA | [h] Suncoast Gerontology and Alzheimer's Center, University of South Florida College of Medicine, Tampa, FL, USA
Correspondence: [*] Corresponding author: Gary W. Arendash, Ph.D., Department of Cell Biology, Microbiology, & Molecular Biology, University of South Florida, Tampa, FL 33620, USA. Tel.: +1 813 974 1584; Fax: +1 813 974 1614; E-mail: [email protected].
Abstract: Recent epidemiologic studies suggest that caffeine may be protective against Alzheimer's disease (AD). Supportive of this premise, our previous studies have shown that moderate caffeine administration protects/restores cognitive function and suppresses brain amyloid-β (Aβ) production in AD transgenic mice. In the present study, we report that acute caffeine administration to both young adult and aged AD transgenic mice rapidly reduces Aβ levels in both brain interstitial fluid and plasma without affecting Aβ elimination. Long-term oral caffeine treatment to aged AD mice provided not only sustained reductions in plasma Aβ, but also decreases in both soluble and deposited Aβ in hippocampus and cortex. Irrespective of caffeine treatment, plasma Aβ levels did not correlate with brain Aβ levels or with cognitive performance in individual aged AD mice. Although higher plasma caffeine levels were strongly associated with lower plasma Aβ1-40 levels in aged AD mice, plasma caffeine levels were also not linked to cognitive performance. Plasma caffeine and theophylline levels were tightly correlated, both being associated with reduced inflammatory cytokine levels in hippocampus. Our conclusion is two-fold: first, that both plasma and brain Aβ levels are reduced by acute or chronic caffeine administration in several AD transgenic lines and ages, indicating a therapeutic value of caffeine against AD; and second, that plasma Aβ levels are not an accurate index of brain Aβ levels/deposition or cognitive performance in aged AD mice.
Keywords: Alzheimer's disease, amyloid-β, brain interstitial fluid, caffeine, plasma, transgenic mice
DOI: 10.3233/JAD-2009-1071
Journal: Journal of Alzheimer's Disease, vol. 17, no. 3, pp. 681-697, 2009
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]